Test Price
2,800 AED✅ Home Collection Available
KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & temperature‑controlled cold‑chain home collection available daily 8 AM–11 PM.
Clinical Guidance: Telephonic post‑test interpretation with a consultant medical geneticist.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The KARS1 gene NGS test screens for autosomal recessive deafness type 89, a rare genetic hearing loss condition caused by mutations in the lysyl‑tRNA synthetase gene. This test is vital for early diagnosis, genetic counseling, and family planning in the UAE’s diverse population.
| Feature | Our KARS1 NGS Test | Standard Single‑Gene Test |
|---|---|---|
| Precision | 99.9% specificity & full coding region coverage | Limited to known hotspots, lower resolution |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing or targeted genotyping |
| Turnaround | 3–4 Weeks | Often 5–7 Weeks or more |
| Sample Type | Blood, Extracted DNA, or 1‑drop Blood on FTA Card | Typically blood only |
Physician Insight & Safety Protocols
🩺 A Note from Lina Osama Zaki Quteineh (DHA 9294403): “Genetic test results provide powerful molecular confirmation, but they must be interpreted alongside your complete clinical history, audiometric evaluation, and family pedigree. I strongly advise discussing all findings with a medical geneticist before making any medical decisions.”
⚠️ Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results do not replace ongoing audiological or medical management.
🛡️ Patient Safety & Exclusion Criteria
- Exclusion: Testing of minors without parental/legal guardian consent is strictly prohibited in compliance with UAE Federal Law No. 2 of 2019.
- Exclusion: Inability to provide informed consent or a reliable clinical history of hearing loss.
- ER Red Flag: Sudden unilateral hearing loss with severe vertigo – seek emergency care immediately.
- ER Red Flag: New‑onset neurological symptoms (facial weakness, imbalance) accompanying hearing changes.
- If you experience acute auditory or neurological signs, visit your nearest emergency department before completing sample collection.
Patient FAQ & Clinical Guidance
1. Why is the KARS1 gene test recommended for hereditary deafness?
This test identifies pathogenic variants in the KARS1 gene causing autosomal recessive deafness type 89 with 99.9% precision. It enables definitive molecular diagnosis, accurate recurrence risk assessment, and targeted audiological intervention. Early detection can guide cochlear implant candidacy and family planning.
2. How is the sample collected and what are the requirements?
A hospital‑grade phlebotomist visits your home for a single blood draw or finger‑prick FTA card collection in 8 am–11 pm slots. You must provide a detailed clinical history and a genetic counselling‑drawn pedigree chart. The sample is transported in ISO‑certified cold‑chain to maintain DNA integrity.
3. Will my insurance cover this KARS1 genetic test in the UAE?
Many UAE insurers cover medically indicated genetic tests for hereditary hearing loss when ordered by an ENT or genetics specialist. Our team verifies your coverage via WhatsApp at +971 54 548 8731 before collection and provides direct billing approval to your facility.
UAE Regulatory & Data Privacy Adherence
Legal & Privacy Compliance
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All processes are performed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Genetic counselling is mandatory prior to testing. All data is stored securely within the UAE’s sovereign health cloud infrastructure.
Clinical & Logistical Metadata
| Test Name | KARS1 Gene Deafness Autosomal Recessive Type 89 NGS Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Blood, Extracted DNA, or FTA Card Dried Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coding Region & Flanking Intronic Regions |
| ICD-10-CM Code | H90.8 (Other sensorineural hearing loss) |
| LOINC Code | 55303-1 (Gene mutation analysis for hereditary hearing loss panel) |
| DHA Facility License & Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians